List of Tables
    Table 1. Ophthalmology Disorders Drug Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Ophthalmology Disorders Drug Market Trends
    Table 3. Ophthalmology Disorders Drug Market Drivers
    Table 4. Ophthalmology Disorders Drug Market Challenges
    Table 5. Ophthalmology Disorders Drug Market Restraints
    Table 6. Global Ophthalmology Disorders Drug Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Ophthalmology Disorders Drug Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Ophthalmology Disorders Drug Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Ophthalmology Disorders Drug Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Ophthalmology Disorders Drug Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Ophthalmology Disorders Drug Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Ophthalmology Disorders Drug Revenue Share by Player, 2017-2022
    Table 13. Global Ophthalmology Disorders Drug Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Ophthalmology Disorders Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmology Disorders Drug as of 2021)
    Table 15. Top Players of Ophthalmology Disorders Drug in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Ophthalmology Disorders Drug Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Ophthalmology Disorders Drug Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Ophthalmology Disorders Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Ophthalmology Disorders Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Ophthalmology Disorders Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Ophthalmology Disorders Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Ophthalmology Disorders Drug Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Ophthalmology Disorders Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Ophthalmology Disorders Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Ophthalmology Disorders Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Ophthalmology Disorders Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Ophthalmology Disorders Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Sanofi Company Details
    Table 31. Sanofi Business Overview
    Table 32. Sanofi Ophthalmology Disorders Drug Product
    Table 33. Sanofi Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 34. Sanofi Recent Development
    Table 35. Bayer Company Details
    Table 36. Bayer Business Overview
    Table 37. Bayer Ophthalmology Disorders Drug Product
    Table 38. Bayer Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 39. Bayer Recent Development
    Table 40. Bausch + Lomb Company Details
    Table 41. Bausch + Lomb Business Overview
    Table 42. Bausch + Lomb Ophthalmology Disorders Drug Product
    Table 43. Bausch + Lomb Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 44. Bausch + Lomb Recent Development
    Table 45. Novartis Company Details
    Table 46. Novartis Business Overview
    Table 47. Novartis Ophthalmology Disorders Drug Product
    Table 48. Novartis Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 49. Novartis Recent Development
    Table 50. Usher Syndrome Company Details
    Table 51. Usher Syndrome Business Overview
    Table 52. Usher Syndrome Ophthalmology Disorders Drug Product
    Table 53. Usher Syndrome Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 54. Usher Syndrome Recent Development
    Table 55. Takeda Pharmaceutical Company Details
    Table 56. Takeda Pharmaceutical Business Overview
    Table 57. Takeda Pharmaceutical Ophthalmology Disorders Drug Product
    Table 58. Takeda Pharmaceutical Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 59. Takeda Pharmaceutical Recent Development
    Table 60. Roche Company Details
    Table 61. Roche Business Overview
    Table 62. Roche Ophthalmology Disorders Drug Product
    Table 63. Roche Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 64. Roche Recent Development
    Table 65. Pfizer Company Details
    Table 66. Pfizer Business Overview
    Table 67. Pfizer Ophthalmology Disorders Drug Product
    Table 68. Pfizer Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 69. Pfizer Recent Development
    Table 70. Allergan Company Details
    Table 71. Allergan Business Overview
    Table 72. Allergan Ophthalmology Disorders Drug Product
    Table 73. Allergan Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 74. Allergan Recent Development
    Table 75. Gilead Sciences Company Details
    Table 76. Gilead Sciences Business Overview
    Table 77. Gilead Sciences Ophthalmology Disorders Drug Product
    Table 78. Gilead Sciences Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 79. Gilead Sciences Recent Development
    Table 80. Kubota Pharmaceutical Company Details
    Table 81. Kubota Pharmaceutical Business Overview
    Table 82. Kubota Pharmaceutical Ophthalmology Disorders Drug Product
    Table 83. Kubota Pharmaceutical Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 84. Kubota Pharmaceutical Recent Development
    Table 85. Alkeus Pharmaceuticals Company Details
    Table 86. Alkeus Pharmaceuticals Business Overview
    Table 87. Alkeus Pharmaceuticals Ophthalmology Disorders Drug Product
    Table 88. Alkeus Pharmaceuticals Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 89. Alkeus Pharmaceuticals Recent Development
    Table 90. Astellas Pharma Company Details
    Table 91. Astellas Pharma Business Overview
    Table 92. Astellas Pharma Ophthalmology Disorders Drug Product
    Table 93. Astellas Pharma Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 94. Astellas Pharma Recent Development
    Table 95. Ferrer Corporate Company Details
    Table 96. Ferrer Corporate Business Overview
    Table 97. Ferrer Corporate Ophthalmology Disorders Drug Product
    Table 98. Ferrer Corporate Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 99. Ferrer Corporate Recent Development
    Table 100. Amgen Inc Company Details
    Table 101. Amgen Inc Business Overview
    Table 102. Amgen Inc Ophthalmology Disorders Drug Product
    Table 103. Amgen Inc Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 104. Amgen Inc Recent Development
    Table 105. Editas Medicine Inc Company Details
    Table 106. Editas Medicine Inc Business Overview
    Table 107. Editas Medicine Inc Ophthalmology Disorders Drug Product
    Table 108. Editas Medicine Inc Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 109. Editas Medicine Inc Recent Development
    Table 110. ProQR Therapeutics NV Company Details
    Table 111. ProQR Therapeutics NV Business Overview
    Table 112. ProQR Therapeutics NV Ophthalmology Disorders Drug Product
    Table 113. ProQR Therapeutics NV Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 114. ProQR Therapeutics NV Recent Development
    Table 115. ReNeuron Company Details
    Table 116. ReNeuron Business Overview
    Table 117. ReNeuron Ophthalmology Disorders Drug Product
    Table 118. ReNeuron Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 119. ReNeuron Recent Development
    Table 120. Amarantus BioScience Company Details
    Table 121. Amarantus BioScience Business Overview
    Table 122. Amarantus BioScience Ophthalmology Disorders Drug Product
    Table 123. Amarantus BioScience Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 124. Amarantus BioScience Recent Development
    Table 125. Ocugen Company Details
    Table 126. Ocugen Business Overview
    Table 127. Ocugen Ophthalmology Disorders Drug Product
    Table 128. Ocugen Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 129. Ocugen Recent Development
    Table 130. ReGenX Biosciences Company Details
    Table 131. ReGenX Biosciences Business Overview
    Table 132. ReGenX Biosciences Ophthalmology Disorders Drug Product
    Table 133. ReGenX Biosciences Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 134. ReGenX Biosciences Recent Development
    Table 135. Sucampo Pharmaceuticals Company Details
    Table 136. Sucampo Pharmaceuticals Business Overview
    Table 137. Sucampo Pharmaceuticals Ophthalmology Disorders Drug Product
    Table 138. Sucampo Pharmaceuticals Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 139. Sucampo Pharmaceuticals Recent Development
    Table 140. Orphagen Pharmaceuticals Company Details
    Table 141. Orphagen Pharmaceuticals Business Overview
    Table 142. Orphagen Pharmaceuticals Ophthalmology Disorders Drug Product
    Table 143. Orphagen Pharmaceuticals Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 144. Orphagen Pharmaceuticals Recent Development
    Table 145. Okuvision Company Details
    Table 146. Okuvision Business Overview
    Table 147. Okuvision Ophthalmology Disorders Drug Product
    Table 148. Okuvision Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 149. Okuvision Recent Development
    Table 150. Second Sight Medical Company Details
    Table 151. Second Sight Medical Business Overview
    Table 152. Second Sight Medical Ophthalmology Disorders Drug Product
    Table 153. Second Sight Medical Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 154. Second Sight Medical Recent Development
    Table 155. Acucela Company Details
    Table 156. Acucela Business Overview
    Table 157. Acucela Ophthalmology Disorders Drug Product
    Table 158. Acucela Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 159. Acucela Recent Development
    Table 160. Stealth BioTherapeutics Company Details
    Table 161. Stealth BioTherapeutics Business Overview
    Table 162. Stealth BioTherapeutics Ophthalmology Disorders Drug Product
    Table 163. Stealth BioTherapeutics Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 164. Stealth BioTherapeutics Recent Development
    Table 165. Sun Pharma Advanced Research Company Company Details
    Table 166. Sun Pharma Advanced Research Company Business Overview
    Table 167. Sun Pharma Advanced Research Company Ophthalmology Disorders Drug Product
    Table 168. Sun Pharma Advanced Research Company Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 169. Sun Pharma Advanced Research Company Recent Development
    Table 170. AmpliPhi Biosciences Company Details
    Table 171. AmpliPhi Biosciences Business Overview
    Table 172. AmpliPhi Biosciences Ophthalmology Disorders Drug Product
    Table 173. AmpliPhi Biosciences Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 174. AmpliPhi Biosciences Recent Development
    Table 175. Applied Genetic Technologies Company Details
    Table 176. Applied Genetic Technologies Business Overview
    Table 177. Applied Genetic Technologies Ophthalmology Disorders Drug Product
    Table 178. Applied Genetic Technologies Revenue in Ophthalmology Disorders Drug Business (2017-2022) & (US$ Million)
    Table 179. Applied Genetic Technologies Recent Development
    Table 180. Asklepios BioPharmaceutical Details
    Table 181. Biovista Details
    Table 182. Spark Therapeutics Details
    Table 183. Caladrius Biosciences Details
    Table 184. Dompe Farmaceutici Details
    Table 185. Dormant Projects Details
    Table 186. Grupo Ferrer Internacional Details
    Table 187. ID Pharma Details
    Table 188. InFlectis BioScience Details
    Table 189. Ionis Pharmaceuticals Details
    Table 190. Ixchel Pharma Details
    Table 191. Khondrion Details
    Table 192. Mimetogen Pharmaceuticals Details
    Table 193. Mitotech Details
    Table 194. M's Science Details
    Table 195. Nanovector Details
    Table 196. SanBio Details
    Table 197. Research Programs/Design for This Report
    Table 198. Key Data Information from Secondary Sources
    Table 199. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ophthalmology Disorders Drug Product Picture
    Figure 2. Global Ophthalmology Disorders Drug Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Ophthalmology Disorders Drug Market Size 2017-2028 (US$ Million)
    Figure 4. United States Ophthalmology Disorders Drug Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Ophthalmology Disorders Drug Market Size 2017-2028 (US$ Million)
    Figure 6. United States Ophthalmology Disorders Drug Market Share in Global 2017-2028
    Figure 7. Ophthalmology Disorders Drug Report Years Considered
    Figure 8. Product Picture of Oral
    Figure 9. Product Picture of Injection
    Figure 10. Product Picture of External Use
    Figure 11. Global Ophthalmology Disorders Drug Market Share by Type in 2022 & 2028
    Figure 12. Global Ophthalmology Disorders Drug Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Ophthalmology Disorders Drug Market Share by Type (2017-2028)
    Figure 14. United States Ophthalmology Disorders Drug Market Share by Type in 2022 & 2028
    Figure 15. United States Ophthalmology Disorders Drug Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Ophthalmology Disorders Drug Market Share by Type (2017-2028)
    Figure 17. Product Picture of Juvenile Macular Degeneration (Stargardt Disease)
    Figure 18. Product Picture of Leber Congenital Amaurosis (LCA)
    Figure 19. Product Picture of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)
    Figure 20. Product Picture of Usher Syndrome
    Figure 21. Product Picture of Retinitis Pigmentosa (Retinitis)
    Figure 22. Global Ophthalmology Disorders Drug Market Share by Application in 2022 & 2028
    Figure 23. Global Ophthalmology Disorders Drug Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Ophthalmology Disorders Drug Market Share by Application (2017-2028)
    Figure 25. United States Ophthalmology Disorders Drug Market Share by Application in 2022 & 2028
    Figure 26. United States Ophthalmology Disorders Drug Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Ophthalmology Disorders Drug Market Share by Application (2017-2028)
    Figure 28. North America Ophthalmology Disorders Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Ophthalmology Disorders Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Ophthalmology Disorders Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Ophthalmology Disorders Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Ophthalmology Disorders Drug Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. U.A.E Ophthalmology Disorders Drug Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Sanofi Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 57. Bayer Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 58. Bausch + Lomb Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 59. Novartis Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 60. Usher Syndrome Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 61. Takeda Pharmaceutical Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 62. Roche Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 63. Pfizer Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 64. Allergan Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 65. Gilead Sciences Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 66. Kubota Pharmaceutical Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 67. Alkeus Pharmaceuticals Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 68. Astellas Pharma Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 69. Ferrer Corporate Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 70. Amgen Inc Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 71. Editas Medicine Inc Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 72. ProQR Therapeutics NV Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 73. ReNeuron Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 74. Amarantus BioScience Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 75. Ocugen Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 76. ReGenX Biosciences Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 77. Sucampo Pharmaceuticals Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 78. Orphagen Pharmaceuticals Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 79. Okuvision Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 80. Second Sight Medical Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 81. Acucela Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 82. Stealth BioTherapeutics Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 83. Sun Pharma Advanced Research Company Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 84. AmpliPhi Biosciences Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 85. Applied Genetic Technologies Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 86. Asklepios BioPharmaceutical Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 87. Biovista Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 88. Spark Therapeutics Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 89. Caladrius Biosciences Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 90. Dompe Farmaceutici Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 91. Dormant Projects Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 92. Grupo Ferrer Internacional Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 93. ID Pharma Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 94. InFlectis BioScience Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 95. Ionis Pharmaceuticals Revenue Growth Rate in Ophthalmology Disorders Drug Business (2017-2022)
    Figure 96. Bottom-up and Top-down Approaches for This Report
    Figure 97. Data Triangulation
    Figure 98. Key Executives Interviewed